These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23905578)

  • 1. Small magnetite antiretroviral therapeutic nanoparticle probes for MRI of drug biodistribution.
    Guo D; Li T; McMillan J; Sajja BR; Puligujja P; Boska MD; Gendelman HE; Liu XM
    Nanomedicine (Lond); 2014 Jul; 9(9):1341-52. PubMed ID: 23905578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging of folic acid-coated magnetite nanoparticles reflects tissue biodistribution of long-acting antiretroviral therapy.
    Li T; Gendelman HE; Zhang G; Puligujja P; McMillan JM; Bronich TK; Edagwa B; Liu XM; Boska MD
    Int J Nanomedicine; 2015; 10():3779-90. PubMed ID: 26082630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infections.
    Puligujja P; McMillan J; Kendrick L; Li T; Balkundi S; Smith N; Veerubhotla RS; Edagwa BJ; Kabanov AV; Bronich T; Gendelman HE; Liu XM
    Nanomedicine; 2013 Nov; 9(8):1263-73. PubMed ID: 23680933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice.
    Dash PK; Gendelman HE; Roy U; Balkundi S; Alnouti Y; Mosley RL; Gelbard HA; McMillan J; Gorantla S; Poluektova LY
    AIDS; 2012 Nov; 26(17):2135-44. PubMed ID: 22824628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Europium sulfide nanoprobes predict antiretroviral drug delivery into HIV-1 cell and tissue reservoirs.
    Herskovitz J; Hasan M; Machhi J; Mukadam I; Ottemann BM; Hilaire JR; Woldstad C; McMillan J; Liu Y; Seravalli J; Sarella A; Gendelman HE; Kevadiya BD
    Nanotheranostics; 2021; 5(4):417-430. PubMed ID: 33972918
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioimaging predictors of rilpivirine biodistribution and antiretroviral activities.
    Ottemann BM; Helmink AJ; Zhang W; Mukadam I; Woldstad C; Hilaire JR; Liu Y; McMillan JM; Edagwa BJ; Mosley RL; Garrison JC; Kevadiya BD; Gendelman HE
    Biomaterials; 2018 Dec; 185():174-193. PubMed ID: 30245386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues.
    Kevadiya BD; Ottemann B; Mukadam IZ; Castellanos L; Sikora K; Hilaire JR; Machhi J; Herskovitz J; Soni D; Hasan M; Zhang W; Anandakumar S; Garrison J; McMillan J; Edagwa B; Mosley RL; Vachet RW; Gendelman HE
    Theranostics; 2020; 10(2):630-656. PubMed ID: 31903142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative magnetic resonance and SPECT imaging for macrophage tissue migration and nanoformulated drug delivery.
    Gorantla S; Dou H; Boska M; Destache CJ; Nelson J; Poluektova L; Rabinow BE; Gendelman HE; Mosley RL
    J Leukoc Biol; 2006 Nov; 80(5):1165-74. PubMed ID: 16908517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging.
    Asem H; Zhao Y; Ye F; Barrefelt Å; Abedi-Valugerdi M; El-Sayed R; El-Serafi I; Abu-Salah KM; Hamm J; Muhammed M; Hassan M
    J Nanobiotechnology; 2016 Dec; 14(1):82. PubMed ID: 27993139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical pharmacokinetics and tissue distribution of long-acting nanoformulated antiretroviral therapy.
    Gautam N; Roy U; Balkundi S; Puligujja P; Guo D; Smith N; Liu XM; Lamberty B; Morsey B; Fox HS; McMillan J; Gendelman HE; Alnouti Y
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3110-20. PubMed ID: 23612193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy.
    Martinez-Skinner AL; Araínga MA; Puligujja P; Palandri DL; Baldridge HM; Edagwa BJ; McMillan JM; Mosley RL; Gendelman HE
    PLoS One; 2015; 10(12):e0145966. PubMed ID: 26716700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations.
    Puligujja P; Balkundi SS; Kendrick LM; Baldridge HM; Hilaire JR; Bade AN; Dash PK; Zhang G; Poluektova LY; Gorantla S; Liu XM; Ying T; Feng Y; Wang Y; Dimitrov DS; McMillan JM; Gendelman HE
    Biomaterials; 2015 Feb; 41():141-50. PubMed ID: 25522973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating cellular autophagy for controlled antiretroviral drug release.
    Thomas MB; Gnanadhas DP; Dash PK; Machhi J; Lin Z; McMillan J; Edagwa B; Gelbard H; Gendelman HE; Gorantla S
    Nanomedicine (Lond); 2018 Sep; 13(17):2139-2154. PubMed ID: 30129397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term biodistribution and biocompatibility investigation of dextran-coated magnetite nanoparticle using mice as the animal model.
    Estevanato LL; Lacava LM; Carvalho LC; Azevedo RB; Silva O; Pelegrini F; Báo SN; Morais PC; Lacava ZG
    J Biomed Nanotechnol; 2012 Apr; 8(2):301-8. PubMed ID: 22515081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells.
    Kanmogne GD; Singh S; Roy U; Liu X; McMillan J; Gorantla S; Balkundi S; Smith N; Alnouti Y; Gautam N; Zhou Y; Poluektova L; Kabanov A; Bronich T; Gendelman HE
    Int J Nanomedicine; 2012; 7():2373-88. PubMed ID: 22661891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies.
    Edagwa BJ; Zhou T; McMillan JM; Liu XM; Gendelman HE
    Curr Med Chem; 2014; 21(36):4186-98. PubMed ID: 25174930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell Biodistribution.
    Kevadiya BD; Woldstad C; Ottemann BM; Dash P; Sajja BR; Lamberty B; Morsey B; Kocher T; Dutta R; Bade AN; Liu Y; Callen SE; Fox HS; Byrareddy SN; McMillan JM; Bronich TK; Edagwa BJ; Boska MD; Gendelman HE
    Theranostics; 2018; 8(1):256-276. PubMed ID: 29290806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles.
    Zhou T; Su H; Dash P; Lin Z; Dyavar Shetty BL; Kocher T; Szlachetka A; Lamberty B; Fox HS; Poluektova L; Gorantla S; McMillan J; Gautam N; Mosley RL; Alnouti Y; Edagwa B; Gendelman HE
    Biomaterials; 2018 Jan; 151():53-65. PubMed ID: 29059541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods development for blood borne macrophage carriage of nanoformulated antiretroviral drugs.
    Balkundi S; Nowacek AS; Roy U; Martinez-Skinner A; McMillan J; Gendelman HE
    J Vis Exp; 2010 Dec; (46):. PubMed ID: 21178968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.